Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Sareum Holdings

    MCap

    GBP23m

    Last close

    GBP0.16

    ▲ −0.75 (−4.41%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Electro Optic Systems

    MCap

    AUD1,639m

    Last close

    AUD8.49

    ▲ 1.22 (16.78%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Sparks commentary

Healthcare

Sparks

Kuros Biosciences (SWX: KURN) surges on raised guidance
Published by Finlay Mathers

Kuros Biosciences raised its 2025 sales guidance to at least 70% growth after reporting a 77% revenue surge to $101.1m for the first nine months of 2025. The Swiss medical device company’s Direct MagnetOs sales jumped 76% to $99.7m, driven by strong demand for its bone graft technology. Kuros reported EBITDA of $7.4m, up from $1.6m a year earlier, delivering a 12.1% adjusted EBITDA margin. The company launched its MagnetOs MIS Delivery System in the US following FDA clearance and secured Saudi Food and Drug Authority approval for MagnetOs Putty and Granules.

Next Sparks Commentary in this sector >

Latest

Healthcare | Comment

BioVersys (SIX:BIOV) moves closer to Phase III with CTA filing

Healthcare | Comment

Basilea (SIX: BSLN) enters into antibiotic discovery partnership with Phare Bio

Consumer | Comment

BAT (LSE: BATS) – FY25 profit in line with guidance, FY26 guidance at low end of medium-term growth range

Healthcare | Comment

OSE Immunotherapeutics (PAR: OSE) – AbbVie partnership amendment

Industrials | Comment

Ocean Wilsons (LON: OCN) – Suspension, de-listing and cancellation of trading